BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 8054502)

  • 1. Reduced oxygenation in a rat mammary carcinoma post-radiation and reoxygenation with a perflubron emulsion/carbogen breathing.
    Teicher BA; Dupuis NP; Robinson MF; Kusumoto T; Liu M; Menon K
    In Vivo; 1994; 8(1):125-31. PubMed ID: 8054502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Restoration of tumor oxygenation after cytotoxic therapy by a perflubron emulsion/carbogen breathing.
    Dupuis NP; Kusumoto T; Robinson MF; Liu F; Menon K; Teicher BA
    Artif Cells Blood Substit Immobil Biotechnol; 1995; 23(3):423-9. PubMed ID: 7493063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiosensitization of murine tumors by Fluosol-DA 20%.
    Lee I; Levitt SH; Song CW
    Radiat Res; 1990 Jun; 122(3):275-9. PubMed ID: 2113298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Fluosol DA 20% and carbogen on the radioresponse of SCK tumors and skin of A/J mice.
    Lee I; Levitt SH; Song CW
    Radiat Res; 1987 Oct; 112(1):173-82. PubMed ID: 3116597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of a perfluorochemical emulsion on the response of BA1112 rat rhabdomyosarcomas to continuous low-dose-rate irradiation.
    Morton JD; Porter E; Yabuki H; Nath R; Rockwell S
    Radiat Res; 1990 Nov; 124(2):178-82. PubMed ID: 2123353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Noninvasive monitoring of carbogen-induced changes in tumor blood flow and oxygenation by functional magnetic resonance imaging.
    Robinson SP; Howe FA; Griffiths JR
    Int J Radiat Oncol Biol Phys; 1995 Nov; 33(4):855-9. PubMed ID: 7591894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of various oxygenation conditions on the enhancement by Fluosol-DA of melphalan antitumor activity.
    Teicher BA; Crawford JM; Holden SA; Cathcart KN
    Cancer Res; 1987 Oct; 47(19):5036-41. PubMed ID: 3113727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of a perfluorochemical emulsion on the radiation response of BA1112 rhabdomyosarcomas.
    Martin DF; Porter EA; Fischer JJ; Rockwell S
    Radiat Res; 1987 Oct; 112(1):45-53. PubMed ID: 3116598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Approaches to defining the mechanism of enhancement by Fluosol-DA 20% with carbogen of melphalan antitumor activity.
    Teicher BA; Holden SA; Jacobs JL
    Cancer Res; 1987 Jan; 47(2):513-8. PubMed ID: 3098413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increase in pO2 and radiosensitivity of tumors by Fluosol-DA (20%) and carbogen.
    Song CW; Lee I; Hasegawa T; Rhee JG; Levitt SH
    Cancer Res; 1987 Jan; 47(2):442-6. PubMed ID: 3098409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimization of perfluorochemical levels with radiation therapy in mice.
    Teicher BA; Herman TS; Jones SM
    Cancer Res; 1989 May; 49(10):2693-7. PubMed ID: 2713854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modification of photodynamic therapy-induced hypoxia by fluosol-DA (20%) and carbogen breathing in mice.
    Fingar VH; Mang TS; Henderson BW
    Cancer Res; 1988 Jun; 48(12):3350-4. PubMed ID: 3130983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reoxygenation in a C3H mouse mammary carcinoma. The importance of chronic rather than acute hypoxia.
    Horsman MR; Grau C; Overgaard J
    Acta Oncol; 1995; 34(3):325-8. PubMed ID: 7779417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in radiation sensitization induced by Fluosol-DA as measured by 31P nuclear magnetic resonance spectroscopy.
    Koutcher JA; Alfieri AA; Kornblith AB; Devitt ML; Cowburn D; Ballon D; Kim JH
    Cancer Res; 1990 Nov; 50(22):7252-6. PubMed ID: 2121332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The mechanisms by which hyperbaric oxygen and carbogen improve tumour oxygenation.
    Brizel DM; Lin S; Johnson JL; Brooks J; Dewhirst MW; Piantadosi CA
    Br J Cancer; 1995 Nov; 72(5):1120-4. PubMed ID: 7577456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of an anti-angiogenic treatment on 9L gliosarcoma: oxygenation and response to cytotoxic therapy.
    Teicher BA; Holden SA; Ara G; Dupuis NP; Liu F; Yuan J; Ikebe M; Kakeji Y
    Int J Cancer; 1995 May; 61(5):732-7. PubMed ID: 7768649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of tumor oxygenation and radiosensitivity by a perfluorooctylbromide emulsion.
    Rockwell S; Kelley M; Irvin CG; Hughes CS; Porter E; Yabuki H; Fischer JJ
    Radiother Oncol; 1991 Oct; 22(2):92-8. PubMed ID: 1957007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of oxygen on the cytotoxicity and antitumor activity of etoposide.
    Teicher BA; Holden SA; Rose CM
    J Natl Cancer Inst; 1985 Dec; 75(6):1129-33. PubMed ID: 3934448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increase in tumor pO2 by perfluorochemicals and carbogen.
    Hasegawa T; Rhee JG; Levitt SH; Song CW
    Int J Radiat Oncol Biol Phys; 1987 Apr; 13(4):569-74. PubMed ID: 3104250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survey of the effect of adding Fluosol-DA 20%/O2 to treatment with various chemotherapeutic agents.
    Teicher BA; Holden SA
    Cancer Treat Rep; 1987 Feb; 71(2):173-7. PubMed ID: 3100035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.